NCT01935466View on ClinicalTrials.gov

"Risk of Bladder Cancer in Type 2 Diabetes Patients With Pioglitazone Therapy PROBE"

CompletedOBSERVATIONAL
Enrollment

6,107

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

October 31, 2021

Study Completion Date

October 31, 2021

Conditions
Bladder Cancer
Interventions
DRUG

Pioglitazone

Ever users of Pioglitazone

Trial Locations (1)

160012

Deptt of Endocrinology, Chandigarh

All Listed Sponsors
lead

Post Graduate Institute of Medical Education and Research, Chandigarh

OTHER

NCT01935466 - "Risk of Bladder Cancer in Type 2 Diabetes Patients With Pioglitazone Therapy PROBE" | Biotech Hunter | Biotech Hunter